Overview Meta-analysis - Eltrombopag Status: Completed Trial end date: 2009-10-01 Target enrollment: Participant gender: Summary The purpose of the meta-analysis was to explore the efficacy of eltrombopag versus placebo (standard of care) Details Lead Sponsor: GlaxoSmithKline